BillionToOne, Inc.
Laboratory testing company · Menlo Park, California, United States · Nasdaq: BLLN
BillionToOne, Inc. is a laboratory testing company headquartered in Menlo Park, California, United States. Its shares trade on Nasdaq under the ticker BLLN. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $224,227 in total, most recently in 2018.
BillionToOne at a glance
What does BillionToOne do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $224,227 in total (2018). NIH funding came from the National Heart, Lung, and Blood Institute.
Frequently asked questions about BillionToOne
Where is BillionToOne headquartered?
BillionToOne, Inc. is headquartered in Menlo Park, California, United States.
What does BillionToOne do?
BillionToOne, Inc. is a laboratory testing company. Its SEC industry classification is Services-Medical Laboratories.
Is BillionToOne a public company?
Yes. BillionToOne, Inc. trades on Nasdaq under the ticker BLLN.
Similar companies
- Exact Sciences CorpMadison, Wisconsin, United States
- Guardant Health, Inc.Palo Alto, California, United States
- CareDx, Inc.Brisbane, California, United States
- Biodesix IncLouisville, Colorado, United States
- Dxterity Diagnostics IncCompton, California, United States
- Veracyte, Inc.South San Francisco, California, United States
- Aclarion, Inc.Broomfield, Colorado, United States
- Foundation Medicine, Inc.Cambridge, Massachusetts, United States
Work with CROs and CDMOs like BillionToOne
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.